Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Ronald B. Emeson, Ph.D.

Associate Professor
Researcher

Contact Information:

Vanderbilt University Medical Center
8160B MRB III
Nashville, TN 37232-8548
615-936-1688
Fax: 615-936-1689

Research Description

The research interests of our laboratory focus on the cellular and molecular processes underlying neuronal communication in normal and pathophysiologic disease states. Specifically, we are examining the molecular mechanisms involved in the editing of RNA transcripts encoding proteins critical for mammalian nervous system function. RNA editing is a post-transcriptional modification in which specific adenosine residues in pre-messenger RNAs are converted to inosine (A-to-I editing) by double-stranded RNA-specific adenosine deaminases (ADARs). As a result of these deamination events, the coding potential of RNAs can be subtly altered to change as little as a single amino acid residue in resultant products to generate protein isoforms with distinct functional properties.

Our current research efforts focus upon the physiological importance of RNA editing for transcripts encoding the 2C-subtype of serotonin receptor (5HT2C), a member of the Shaker-family of voltage-gated potassium channels (Kv1.1) and calcium-dependent activator protein for secretion 1 (CAPS1), a protein involved in the fusion of dense core secretory granules. These studies take advantage of heterologous expression systems to assess the functional differences between protein isoforms encoded by edited and non-edited transcripts and subsequently lead to the generation of mutant mouse model systems where we can limit expression to a single protein isoform. For example, mutant mice solely expressing the non-edited form of the 5HT2C receptor demonstrate deficits in maternal behavior, whereas animals solely expressing the fully-edited iso-form have a number of phenotypic alterations characteristic of human Prader-Willi syndrome. The long-term goal of the proposed research is to understand the mechanism(s) underlying the regulation of RNA editing and to define how such RNA processing events may contribute to functional protein diversity and dysfunction in the nervous system.

Publications
  • Zhou C, Ding L, Deel ME, Ferrick EA, Emeson RB, Gallagher MJ. Altered intrathalamic GABAA neurotransmission in a mouse model of a human genetic absence epilepsy syndrome. Neurobiol. Dis [print-electronic]. 2015 Jan; 73: 407-17. PMID: 25447232, PMCID: PMC4418938, PII: S0969-9961(14)00334-9, DOI: 10.1016/j.nbd.2014.10.021, ISSN: 1095-953X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25447232.
  • Ulbricht RJ, Emeson RB. One hundred million adenosine-to-inosine RNA editing sites: hearing through the noise. Bioessays [print-electronic]. 2014 Aug; 36(8): 730-5. PMID: 24889193, PMCID: PMC4359916, DOI: 10.1002/bies.201400055, ISSN: 1521-1878.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24889193.
  • Hood JL, Morabito MV, Martinez CR, Gilbert JA, Ferrick EA, Ayers GD, Chappell JD, Dermody TS, Emeson RB. Reovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions. Mol. Cell. Neurosci [print-electronic]. 2014 Jul; 61: 97-109. PMID: 24906008, PMCID: PMC4134954, PII: S1044-7431(14)00062-1, DOI: 10.1016/j.mcn.2014.06.001, ISSN: 1095-9327.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24906008.
  • Anastasio NC, Stutz SJ, Fox RG, Sears RM, Emeson RB, DiLeone RJ, O'Neil RT, Fink LH, Li D, Green TA, Moeller FG, Cunningham KA. Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence. Neuropsychopharmacology [print-electronic]. 2014 Jan; 39(2): 370-82. PMID: 23939424, PMCID: PMC3970795, PII: npp2013199, DOI: 10.1038/npp.2013.199, ISSN: 1740-634X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23939424.
  • O'Neil RT, Emeson RB. Quantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disorders. Neurobiol. Dis [print-electronic]. 2012 Jan; 45(1): 8-13. PMID: 21914481, PMCID: PMC3225646, PII: S0969-9961(11)00292-0, DOI: 10.1016/j.nbd.2011.08.026, ISSN: 1095-953X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21914481.
  • Hood JL, Emeson RB. Editing of neurotransmitter receptor and ion channel RNAs in the nervous system. Curr. Top. Microbiol. Immunol. 2012; 353: 61-90. PMID: 21796513, PMCID: PMC4109139, DOI: 10.1007/82_2011_157, ISSN: 0070-217X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21796513.
  • Stefl R, Oberstrass FC, Hood JL, Jourdan M, Zimmermann M, Skrisovska L, Maris C, Peng L, Hofr C, Emeson RB, Allain FH. The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove. Cell. 2010 Oct 10/15/2010; 143(2): 225-37. PMID: 20946981, PMCID: PMC2956598, PII: S0092-8674(10)01074-3, DOI: 10.1016/j.cell.2010.09.026, ISSN: 1097-4172.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20946981.
  • Morabito MV, Abbas AI, Hood JL, Kesterson RA, Jacobs MM, Kump DS, Hachey DL, Roth BL, Emeson RB. Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol. Dis [print-electronic]. 2010 Aug; 39(2): 169-80. PMID: 20394819, PMCID: PMC2906772, PII: S0969-9961(10)00101-4, DOI: 10.1016/j.nbd.2010.04.004, ISSN: 1095-953X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20394819.
  • Morabito MV, Ulbricht RJ, O'Neil RT, Airey DC, Lu P, Zhang B, Wang L, Emeson RB. High-throughput multiplexed transcript analysis yields enhanced resolution of 5-hydroxytryptamine 2C receptor mRNA editing profiles. Mol. Pharmacol [print-electronic]. 2010 Jun; 77(6): 895-902. PMID: 20181818, PMCID: PMC2879922, PII: mol.109.061903, DOI: 10.1124/mol.109.061903, ISSN: 1521-0111.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20181818.
  • Olaghere da Silva UB, Morabito MV, Canal CE, Airey DC, Emeson RB, Sanders-Bush E. Impact of RNA editing on functions of the serotonin 2C receptor in vivo. Front Neurosci. 2010; 4: 26. PMID: 20582266, PMCID: PMC2858556, DOI: 10.3389/neuro.23.001.2010, ISSN: 1662-453X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20582266.
  • Lanfranco MF, Seitz PK, Morabito MV, Emeson RB, Sanders-Bush E, Cunningham KA. An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT(2C)R) in brain. J. Neurosci. Methods [print-electronic]. 2009 May 5/15/2009; 179(2): 247-57. PMID: 19428534, PMCID: PMC3794365, PII: S0165-0270(09)00081-8, DOI: 10.1016/j.jneumeth.2009.01.027, ISSN: 1872-678X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19428534.
  • Morabito MV, Emeson RB. RNA editing as a therapeutic target for CNS disorders. Neuropsychopharmacology. 2009 Jan; 34(1): 246. PMID: 19079070, PII: npp2008159, DOI: 10.1038/npp.2008.159, ISSN: 1740-634X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19079070.
  • Jacobs MM, Fogg RL, Emeson RB, Stanwood GD. ADAR1 and ADAR2 expression and editing activity during forebrain development. Dev. Neurosci [print-electronic]. 2009; 31(3): 223-37. PMID: 19325227, PMCID: PMC2692045, PII: 000210185, DOI: 10.1159/000210185, ISSN: 1421-9859.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19325227.
  • Rula EY, Lagrange AH, Jacobs MM, Hu N, Macdonald RL, Emeson RB. Developmental modulation of GABA(A) receptor function by RNA editing. J. Neurosci. 2008 Jun 6/11/2008; 28(24): 6196-201. PMID: 18550761, PMCID: PMC2746000, PII: 28/24/6196, DOI: 10.1523/JNEUROSCI.0443-08.2008, ISSN: 1529-2401.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/18550761.
  • Huebner AK, Keller J, Catala-Lehnen P, Perkovic S, Streichert T, Emeson RB, Amling M, Schinke T. The role of calcitonin and alpha-calcitonin gene-related peptide in bone formation. Arch. Biochem. Biophys [print-electronic]. 2008 May 5/15/2008; 473(2): 210-7. PMID: 18307972, PII: S0003-9861(08)00075-1, DOI: 10.1016/j.abb.2008.02.013, ISSN: 1096-0384.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/18307972.
  • Thompson BJ, Washington MK, Kurre U, Singh M, Rula EY, Emeson RB. Protective roles of alpha-calcitonin and beta-calcitonin gene-related peptide in spontaneous and experimentally induced colitis. Dig. Dis. Sci [print-electronic]. 2008 Jan; 53(1): 229-41. PMID: 17530400, DOI: 10.1007/s10620-007-9848-7, ISSN: 0163-2116.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17530400.
  • Singh M, Kesterson RA, Jacobs MM, Joers JM, Gore JC, Emeson RB. Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing enzyme ADAR2. J. Biol. Chem [print-electronic]. 2007 Aug 8/3/2007; 282(31): 22448-59. PMID: 17567573, PII: M700265200, DOI: 10.1074/jbc.M700265200, ISSN: 0021-9258.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17567573.
  • Rula EY, Emeson RB. Mouse models to elucidate the functional roles of adenosine-to-inosine editing. Meth. Enzymol. 2007; 424: 333-67. PMID: 17662849, PII: S0076-6879(07)24016-9, DOI: 10.1016/S0076-6879(07)24016-9, ISSN: 0076-6879.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17662849.
  • Huebner AK, Schinke T, Priemel M, Schilling S, Schilling AF, Emeson RB, Rueger JM, Amling M. Calcitonin deficiency in mice progressively results in high bone turnover. J. Bone Miner. Res. 2006 Dec; 21(12): 1924-34. PMID: 17002587, DOI: 10.1359/jbmr.060820, ISSN: 0884-0431.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17002587.
  • Xu M, Wells KS, Emeson RB. Substrate-dependent contribution of double-stranded RNA-binding motifs to ADAR2 function. Mol. Biol. Cell [print-electronic]. 2006 Jul; 17(7): 3211-20. PMID: 16672376, PMCID: PMC1552048, PII: E06-02-0162, DOI: 10.1091/mbc.E06-02-0162, ISSN: 1059-1524.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16672376.
  • Stefl R, Xu M, Skrisovska L, Emeson RB, Allain FH. Structure and specific RNA binding of ADAR2 double-stranded RNA binding motifs. Structure. 2006 Feb; 14(2): 345-55. PMID: 16472753, PII: S0969-2126(06)00044-X, DOI: 10.1016/j.str.2005.11.013, ISSN: 0969-2126.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16472753.
  • Feng Y, Sansam CL, Singh M, Emeson RB. Altered RNA editing in mice lacking ADAR2 autoregulation. Mol. Cell. Biol. 2006 Jan; 26(2): 480-8. PMID: 16382140, PMCID: PMC1346902, PII: 26/2/480, DOI: 10.1128/MCB.26.2.480-488.2006, ISSN: 0270-7306.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16382140.
  • Emeson RB, Morabito MV. Food fight: the NPY-serotonin link between aggression and feeding behavior. Sci. STKE. 2005 Mar 3/29/2005; 2005(277): pe12. PMID: 15798100, PII: stke.2772005pe12, DOI: 10.1126/stke.2772005pe12, ISSN: 1525-8882.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15798100.
  • Stefl R, Skrisovska L, Xu M, Emeson RB, Allain FH. Resonance assignments of the double-stranded RNA-binding domains of adenosine deaminase acting on RNA 2 (ADAR2) [letter]. J. Biomol. NMR. 2005 Jan; 31(1): 71-2. PMID: 15692744, DOI: 10.1007/s10858-004-6058-x, ISSN: 0925-2738.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15692744.
  • Sansam, CL and RB Emeson. MRNA Editing. In: Encyclopedia of Life Sciences. 2005; John Wiley & Sons, Ltd: Chichester: [doi:10.1038/npg.els.0005041].
  • Schinke T, Liese S, Priemel M, Haberland M, Schilling AF, Catala-Lehnen P, Blicharski D, Rueger JM, Gagel RF, Emeson RB, Amling M. Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide. J. Bone Miner. Res [print-electronic]. 2004 Dec; 19(12): 2049-56. PMID: 15537449, DOI: 10.1359/JBMR.040915, ISSN: 0884-0431.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15537449.
  • Dawson TR, Sansam CL, Emeson RB. Structure and sequence determinants required for the RNA editing of ADAR2 substrates. J. Biol. Chem [print-electronic]. 2004 Feb 2/6/2004; 279(6): 4941-51. PMID: 14660658, PII: M310068200, DOI: 10.1074/jbc.M310068200, ISSN: 0021-9258.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/14660658.
  • Sansam CL, Wells KS, Emeson RB. Modulation of RNA editing by functional nucleolar sequestration of ADAR2. Proc. Natl. Acad. Sci. U.S.A [print-electronic]. 2003 Nov 11/25/2003; 100(24): 14018-23. PMID: 14612560, PMCID: PMC283538, PII: 2336131100, DOI: 10.1073/pnas.2336131100, ISSN: 0027-8424.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/14612560.
  • Maison SF, Emeson RB, Adams JC, Luebke AE, Liberman MC. Loss of alpha CGRP reduces sound-evoked activity in the cochlear nerve. J. Neurophysiol [print-electronic]. 2003 Nov; 90(5): 2941-9. PMID: 12904337, PII: 00596.2003, DOI: 10.1152/jn.00596.2003, ISSN: 0022-3077.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12904337.
  • Berg KA, Cropper JD, Niswender CM, Sanders-Bush E, Emeson RB, Clarke WP. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br. J. Pharmacol. 2001 Sep; 134(2): 386-92. PMID: 11564657, PMCID: PMC1572953, DOI: 10.1038/sj.bjp.0704255, ISSN: 0007-1188.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11564657.
  • Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, Emeson RB, Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology. 2001 May; 24(5): 478-91. PMID: 11282248, PII: S0893-133X(00)00223-2, DOI: 10.1016/S0893-133X(00)00223-2, ISSN: 0893-133X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11282248.
  • El Meskini R, Jin L, Marx R, Bruzzaniti A, Lee J, Emeson R, Mains R. A signal sequence is sufficient for green fluorescent protein to be routed to regulated secretory granules. Endocrinology. 2001 Feb; 142(2): 864-73. PMID: 11159860, DOI: 10.1210/endo.142.2.7929, ISSN: 0013-7227.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11159860.
  • Gott JM, Emeson RB. Functions and mechanisms of RNA editing. Annu. Rev. Genet. 2000; 34: 499-531. PMID: 11092837, PII: 34/1/499, DOI: 10.1146/annurev.genet.34.1.499, ISSN: 0066-4197.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11092837.
  • Singh M and Emeson RB. Adenosine to Inosine RNA Editing: Substrates and Consequences. RNA Editing: Frontiers in Molecular Biology. (BL Bass, ed.) Oxford University Press:London. 2000; 109-38.
  • Lu JT, Son YJ, Lee J, Jetton TL, Shiota M, Moscoso L, Niswender KD, Loewy AD, Magnuson MA, Sanes JR, Emeson RB. Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development. Mol. Cell. Neurosci. 1999 Aug; 14(2): 99-120. PMID: 10532808, PII: S1044-7431(99)90767-4, DOI: 10.1006/mcne.1999.0767, ISSN: 1044-7431.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/10532808.
  • Liu Y, Emeson RB, Samuel CE. Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1. J. Biol. Chem. 1999 Jun 6/25/1999; 274(26): 18351-8. PMID: 10373439, ISSN: 0021-9258.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/10373439.
  • Rueter SM, Dawson TR, Emeson RB. Regulation of alternative splicing by RNA editing. Nature. 1999 May 5/6/1999; 399(6731): 75-80. PMID: 10331393, DOI: 10.1038/19992, ISSN: 0028-0836.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/10331393.
  • Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, Sanders-Bush E. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J. Biol. Chem. 1999 Apr 4/2/1999; 274(14): 9472-8. PMID: 10092629, ISSN: 0021-9258.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/10092629.
  • Niswender CM, Sanders-Bush E, Emeson RB. Identification and characterization of RNA editing events within the 5-HT2C receptor. Ann. N. Y. Acad. Sci. 1998 Dec 12/15/1998; 861: 38-48. PMID: 9928237, ISSN: 0077-8923.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/9928237.
  • Rueter S and RB Emeson. Adenosine to Inosine Conversion in mRNA. Modification and editing of RNA: the alteration of RNA structure and function. (H. Grosjean and R. Benne, eds.) ASM Press:East Norwalk, CT. 1998; 343-61.
  • Sanes, J.R., E.D. Apel, R.W. Burgess, R.B. Emeson, G. Feng, M. Gautam, D. Glass, R.M. Grady, E. Krejci, J.W. Lichtman, J.T. Lu, J. Massoulie, J.H. Miner, L.M. Moscoso, Q. Nguyen, M. Nichol, P.G. Noakes, B.L. Patton, Y.J. Son, G.D. Yancopoulos and H. Zhou. Development of the neuromuscular junction: genetic analysis in mice. J Physiol Paris. 1998; 92: 167 172.
  • Bass BL, Nishikura K, Keller W, Seeburg PH, Emeson RB, O'Connell MA, Samuel CE, Herbert A. A standardized nomenclature for adenosine deaminases that act on RNA [letter]. RNA. 1997 Sep; 3(9): 947-9. PMID: 9292492, PMCID: PMC1369539, ISSN: 1355-8382.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/9292492.
  • Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature. 1997 May 5/15/1997; 387(6630): 303-8. PMID: 9153397, DOI: 10.1038/387303a0, ISSN: 0028-0836.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/9153397.
  • Breyer RM, Emeson RB, Davis LS, Breyer MD. Structure and localization of the rabbit prostaglandin EP3 receptor. Adv. Exp. Med. Biol. 1997; 400A: 261-8. PMID: 9547567, ISSN: 0065-2598.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/9547567.
  • Canton H, Emeson RB, Barker EL, Backstrom JR, Lu JT, Chang MS, Sanders-Bush E. Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Mol. Pharmacol. 1996 Oct; 50(4): 799-807. PMID: 8863824, ISSN: 0026-895X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8863824.
  • Emeson, R.B. Post-transcriptional regulation of calcitonin gene-related peptide (CGRP) mRNA production. Neurogenic Inflammation. (P. Geppetti and P. Holzer, eds.), CRC Press, Boca Raton, FL. 1996; 15-30.
  • Simpson L, Emeson RB. RNA editing. Annu. Rev. Neurosci. 1996; 19: 27-52. PMID: 8833435, DOI: 10.1146/annurev.ne.19.030196.000331, ISSN: 0147-006X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8833435.
  • Rueter SM, Burns CM, Coode SA, Mookherjee P, Emeson RB. Glutamate receptor RNA editing in vitro by enzymatic conversion of adenosine to inosine. Science. 1995 Mar 3/10/1995; 267(5203): 1491-4. PMID: 7878468, ISSN: 0036-8075.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/7878468.
  • Breyer RM, Emeson RB, Tarng JL, Breyer MD, Davis LS, Abromson RM, Ferrenbach SM. Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor. J. Biol. Chem. 1994 Feb 2/25/1994; 269(8): 6163-9. PMID: 8119961, ISSN: 0021-9258.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8119961.
  • Yeakley JM, Hedjran F, Morfin JP, Merillat N, Rosenfeld MG, Emeson RB. Control of calcitonin/calcitonin gene-related peptide pre-mRNA processing by constitutive intron and exon elements. Mol. Cell. Biol. 1993 Oct; 13(10): 5999-6011. PMID: 8413203, PMCID: PMC364659, ISSN: 0270-7306.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/8413203.
  • Emeson RB, Yeakley JM, Hedjran F, Merillat N, Lenz HJ, Rosenfeld MG. Posttranscriptional regulation of calcitonin/CGRP gene expression. Ann. N. Y. Acad. Sci. 1992 Jun 6/30/1992; 657: 18-35. PMID: 1386208, ISSN: 0077-8923.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/1386208.
  • Rosenfeld MG, Emeson RB, Yeakley JM, Merillat N, Hedjran F, Lenz J, Delsert C. Calcitonin gene-related peptide: a neuropeptide generated as a consequence of tissue-specific, developmentally regulated alternative RNA processing events. Ann. N. Y. Acad. Sci. 1992 Jun 6/30/1992; 657: 1-17. PMID: 1637077, ISSN: 0077-8923.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/1637077.
  • Emeson RB, Hedjran F, Yeakley JM, Guise JW, Rosenfeld MG. Alternative production of calcitonin and CGRP mRNA is regulated at the calcitonin-specific splice acceptor. Nature. 1989 Sep 9/7/1989; 341(6237): 76-80. PMID: 2788825, DOI: 10.1038/341076a0, ISSN: 0028-0836.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/2788825.
  • Rosenfeld M, Crenshaw EB, Emeson R, Leff S, Guise J, Lira S, Nelson C, Nelson C, Russo A. Transcriptional and post-transcriptional strategies in neuroendocrine gene expression. Dev. Biol. (NY). 1988; 5: 317-34. PMID: 3077978.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/3077978.
  • Emeson RB, Eipper BA. Characterization of pro-ACTH/endorphin-derived peptides in rat hypothalamus. J. Neurosci. 1986 Mar; 6(3): 837-49. PMID: 3007691, ISSN: 0270-6474.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/3007691.
  • Emeson RB. Hypothalamic peptidyl-glycine alpha-amidating monooxygenase: preliminary characterization. J. Neurosci. 1984 Oct; 4(10): 2604-13. PMID: 6491725, ISSN: 0270-6474.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/6491725.